Background: Medication-related anticholinergic burden (AB) has been studied mainly in older adults and selectedpatient populations, whereas population-based evidence across adulthood remains limited, particularlyregarding over-the-counter (OTC) drug use and utilization patterns.Objective: To characterize the frequency, distribution, and pharmacological drivers of AB in the German NationalCohort (NAKO).Methods: We conducted a cross-sectional analysis of NAKO baseline data collected in 2014–2019 from partici-pants aged 19–75 years recruited through age- and sex-stratified random sampling from population registries. ABwas quantified from participant-reported seven-day medication use using the German Anticholinergic BurdenScale; cumulative scores ≥ 1 and ≥ 3 defined any and high burden, respectively. Descriptive analyses charac-terized AB by age, sex, drug class, prescription status, and utilization pattern; logistic regression assessed asso-ciations of AB with age, sex, and polypharmacy.Results: Among 199,813 participants (median age 51 years; 50.4% women), 17.4% had any and 3.0% had highAB, with exposure in all analyzed age groups. Any and high AB were associated with female sex (aOR = 1.09,95% CI 1.06–1.12 and aOR = 1.44, 95% CI 1.37–1.53, respectively), most older age groups, and polypharmacy.Nervous system drugs contributed most to aggregate AB. Medications obtained OTC accounted for over one tenthof the sample's burden, with a greater relative contribution in younger age groups. Most anticholinergic drugswere used on a scheduled basis, with daily and long-term use predominating.